The estimated Net Worth of James E Deerfield Mgmt Iii,... is at least $3.61 Milion dollars as of 8 February 2016. James Iii owns over 100,000 units of Editas Medicine Inc stock worth over $3,608,766 and over the last 9 years James sold EDIT stock worth over $0.
James has made over 1 trades of the Editas Medicine Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently James bought 100,000 units of EDIT stock worth $1,600,000 on 8 February 2016.
The largest trade James's ever made was buying 100,000 units of Editas Medicine Inc stock on 8 February 2016 worth over $1,600,000. On average, James trades about 100,000 units every 0 days since 2016. As of 8 February 2016 James still owns at least 954,700 units of Editas Medicine Inc stock.
You can see the complete history of James Iii stock trades at the bottom of the page.
Over the last 9 years, insiders at Editas Medicine Inc have traded over $73,429,036 worth of Editas Medicine Inc stock and bought 241,700 units worth $4,697,822 . The most active insiders traders include Andrew A. F. Hack, Kevin P Starr oraz Kevin Bitterman. On average, Editas Medicine Inc executives and independent directors trade stock every 22 days with the average trade being worth of $126,770. The most recent stock trade was executed by Baisong Mei on 4 September 2024, trading 518 units of EDIT stock currently worth $1,772.
unlocking the promise of genome editing to deliver life-changing medicines. editas medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.
Editas Medicine Inc executives and other stock owners filed with the SEC include: